Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTB4R | Q15722 | 8/20 | 0.46 |
| ▸ | LTB4R2 | Q9NPC1 | 8/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | POLB | P06746 | 3/20 | 0.40 |
| ▸ | APP | P05067 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8418430 | 0.87 | LTB4R (0.52) | LTB4RLTB4R2ALDH1A1POLBAPP | |
| SCHEMBL8418885 | 0.85 | LTB4R (0.65) | LTB4RLTB4R2ALDH1A1POLBAPP | |
| SCHEMBL8564500 | 0.85 | LTB4R (0.65) | LTB4RLTB4R2ALDH1A1POLBAPP | |
| SCHEMBL8571699 | 0.85 | LTB4R (0.52) | LTB4RLTB4R2ALDH1A1POLBAPP | |
| SCHEMBL8418922 | 0.81 | LTB4R (0.57) | LTB4RLTB4R2ALDH1A1POLBMAPT | |
| SCHEMBL8569978 | 0.81 | LTB4R (0.52) | LTB4RLTB4R2ALDH1A1POLBAPP | |
| SCHEMBL8420169 | 0.81 | LTB4R (0.52) | LTB4RLTB4R2ALDH1A1POLBAPP | |
| SCHEMBL8422165 | 0.80 | LTB4R (0.46) | LTB4RLTB4R2ALDH1A1POLBAPP | |
| SCHEMBL8422442 | 0.80 | LTB4R (0.48) | LTB4RLTB4R2ALDH1A1POLBAPP | |
| SCHEMBL8600595 | 0.80 | LTB4R (0.46) | LTB4RLTB4R2ALDH1A1POLBAPP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0942903-A1 | ARYL-SUBSTITUTED ACRYLAMIDES WITH LEUKOTRIENE B4 (LTB-4) RECEPTOR ANTAGONIST ACTIVITY | Novartis AG (CH) | 1999-09-22 | — | — | EP | disclosed |
| WO-1998013347-A1 | ARYL-SUBSTITUTED ACRYLAMIDES WITH LEUKOTRIENE B4 (LTB-4) RECEPTOR ANTAGONIST ACTIVITY | NOVARTIS AG (CH) | 1998-04-02 | — | — | WO | disclosed |